pifithrin has been researched along with 2-(4-morpholinoanilino)-6-cyclohexylaminopurine in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Anastasia, L; Bergante, S; Conforti, E; Creo, P; Doneda, L; Fania, C; Galli, R; Gelfi, C; Lamorte, G; Mazzoleni, S; Palazzolo, G; Papini, N; Piccoli, M; Roncoroni, L; Scaringi, R; Tettamanti, G; Tringali, C; Venerando, B | 1 |
1 other study(ies) available for pifithrin and 2-(4-morpholinoanilino)-6-cyclohexylaminopurine
Article | Year |
---|---|
The synthetic purine reversine selectively induces cell death of cancer cells.
Topics: Antineoplastic Agents; Benzothiazoles; Blotting, Western; Caspases; Cell Cycle Checkpoints; Cell Death; Cell Dedifferentiation; Cell Proliferation; Cell Shape; Cell Survival; Endoreduplication; Enzyme Activation; Fibroblasts; Fibrosarcoma; Flow Cytometry; Gene Silencing; HeLa Cells; Humans; Morpholines; Purines; RNA, Small Interfering; Toluene; Tumor Suppressor Protein p53 | 2012 |